On June 16, 2020 Lilly announced that the FDA has approved a new fast acting insulin. The insulin name will be Lyumjev. It will be on par and in some cases quicker than FIASP or Apridra. of course I am sure in certain circumstances FIASP or Apridra will be faster than Lyumjev. Here is the announcement on the site P&T community web site.
Living in Indianapolis I have heard of this new product for several months now as friends have been working on preparing the documentation for the FDA. Obviously, I did not know the name, or any details only that they were working on a new faster acting insulin.
It is great to have one more choice in this space.